Your session is about to expire
← Back to Search
Procedure
Magnamosis for Intestinal Anastomosis Complication (Magnamosis Trial)
N/A
Waitlist Available
Led By Michael R Harrison, MD
Research Sponsored by Michael Harrison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years postoperation
Awards & highlights
Magnamosis Trial Summary
This trial is testing a new device that may make it easier to connect intestines or other organs during surgery. The device consists of two magnets that are placed inside the organs to be joined. The magnets align and create a connection between the organs. The device is being tested to see if it is safe and effective.
Magnamosis Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years postoperation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years postoperation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of subjects who experience occurrence of anastomotic leak
Secondary outcome measures
Number of patients who have an adequate anastomosis
Number of subjects who experience other device-related complications
Magnamosis Trial Design
1Treatment groups
Experimental Treatment
Group I: MagnamosisExperimental Treatment1 Intervention
Create an intestinal anastomosis using the Magnamosis Magnetic Compression Anastomosis (Magnamosis) device to re-establish intestinal continuity that would otherwise be performed using sutures or stapling devices
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnamosis
2014
N/A
~10
Find a Location
Who is running the clinical trial?
Michael HarrisonLead Sponsor
2 Previous Clinical Trials
25 Total Patients Enrolled
University of California, San FranciscoOTHER
2,506 Previous Clinical Trials
15,238,550 Total Patients Enrolled
Michael R Harrison, MDPrincipal InvestigatorUCSF Professor Emeritus
3 Previous Clinical Trials
35 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger